Manish K. Aghi

Aug 1, 2023 | thejns.org | Manish K. Aghi |Priscilla K Brastianos |Albert Kim |Steven Kalkanis

INTRODUCTIONBrain metastases (BMs), the most common adult intracranial tumor,1 confer a worse prognosis than cancers lacking BMs.2 In this issue of Neurosurgical Focus, we integrate information on advancements in BM management, research that will drive future treatments, and a roadmap for future research.